ACHE and Alzheimer disease: Indeed, five drugs have been approved by the United States Food and Drug Administration (FDA) for the symptomatic treatment of AD, four of which are acetylcholinesterase (AChE) inhibitors: rivastigmine, galantamine, donepezil, and tacrine.